Next Article in Journal
Insights of Improved Aroma under Additional Nitrogen Application at Booting Stage in Fragrant Rice
Previous Article in Journal
Mega Meta-QTLs: A Strategy for the Production of Golden Barley (Hordeum vulgare L.) Tolerant to Abiotic Stresses
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Genes
Volume 13
Issue 11
10.3390/genes13112091
genes-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

The Association between Total Genotype Score and Athletic Performance in Weightlifters

by
Hiroki Homma
1,
Mika Saito
2,
Aoto Saito
2,
Ayumu Kozuma
2,
Ryutaro Matsumoto
3,
Shingo Matsumoto
1,
Naoyuki Kobatake
1,
Takanobu Okamoto
1,2,
Koichi Nakazato
2,4,
Tetsunari Nishiyama
1,2 and
Naoki Kikuchi
1,2,*
1
Faculty of Sport Science, Nippon Sport Science University, Tokyo 158-8508, Japan
2
Graduate School of Health and Sport Science, Nippon Sport Science University, Tokyo 158-8508, Japan
3
Faculty of Education, Ikuei University, Takasaki 370-0011, Japan
4
Faculty of Medical Science, Nippon Sport Science University, Tokyo 158-8508, Japan
*
Author to whom correspondence should be addressed.
Genes 2022, 13(11), 2091; https://doi.org/10.3390/genes13112091
Submission received: 6 October 2022 / Revised: 1 November 2022 / Accepted: 7 November 2022 / Published: 10 November 2022
(This article belongs to the Section Molecular Genetics and Genomics)
Browse Figures
Review Reports Versions Notes

Abstract

:
This study aimed to investigate the relationship between power-oriented genetic polymorphisms and weightlifting status, create a total genotype score (TGS), and validate the association between TGS models and power-oriented athletes. First, 192 weightlifters and 416 controls were studied, and 12 polymorphisms that have previously been associated with strength, power status, and phenotype were genotyped using the TaqMan SNP genotyping assay. We calculated the TGS for the 12 polymorphisms using a PWM (power-oriented whole model) and for 6 of them using a WRM (weightlifting-related model) based on a case–control study. Second, the TGS of the WRM was compared for 177 strength and power athletes and 416 controls. There was no significant difference in the PWM score between weightlifters and the controls. Weightlifters and elite weightlifters had higher WRM scores than the controls. However, the WRM score had no association with weightlifting performance. There was no significant difference in the WRM between power-oriented athletes and the controls. Our study was able to create a TGS model for weightlifters based on case–control results. However, the TGS model could not be applied to other power-oriented athletes.

1. Introduction

Muscle strength and power are dependent on environmental and genetic factors and are required by athletes for successful competition. The genetic factor was estimated to have 66% athletic status heritability. Ahmetov et al. [1] reviewed the association between strength and power, athletic status, and gene markers, and reported at least 38 and 24 strength- and power-related markers. While a single polymorphism is partially responsible for muscle strength variation, the phenotypic influence of these single gene polymorphisms may be limited. Many studies have reported an association between sports performance and the ACTN3 R577X polymorphism; however, this polymorphism may have a low contribution to athletic status and performance. Kikuchi et al. [2] showed that this polymorphism is responsible for 4.6% of the variability in relative peak power using the Wingate anaerobic test, while other studies have reported its contribution to be approximately 2% for muscle strength [3]. Therefore, genetic profiles that are more associated with athletic status and performance are needed.
Some studies have attempted to use the total genotype score (TGS) for the accurate prediction of athletic status and performance [4,5,6,7]. Ben-Zaken et al. created two polygenetic scores for endurance (endurance genetic distance score: EGDS, two and five polymorphisms) and power (power genetic distance score: PGDS, two and five polymorphisms) in related athletes and compared them with those of endurance and power athletes [5]. The PGDS2 and PGDS5 scores of power–speed athletes are significantly higher than their EGDS2 and EGDS5 scores and the PGDS2 and PGDS5 scores of controls. Similarly, the EGDS2 and EGDS5 scores of endurance athletes are significantly higher than their PGDS2 and PGDS5 scores and the EGDS2 and EGDS5 scores of controls. Therefore, polygenetic scores created for each athlete may indicate the athletes’ characteristics.
Several studies involving Japanese participants have not been able to replicate these results [8,9]. Miyamoto-Mikami et al. [8] calculated the TGS based on 21 polymorphisms which have been associated with sprint or power performance and their related phenotypes in 211 Japanese sprint and power athletes and 649 controls; however, the TGS was not able to predict the Japanese sprint and power athletes’ characteristics. In this study, genetic polymorphisms that report the association of sprint and power athlete status, sprint performance, and related phenotypes are used. However, some of these polymorphisms are not directly related to athletic performance factors such as lean body mass and free-fat mass [10,11]. In addition, previous studies recruited athletes in various athletic events involving power/sprint and endurance. To solve these problems, it is necessary to identify relevant genetic polymorphisms in a single athletic event that can clearly identify athletic performance. Weightlifting comprises snatch, clean, and jerk actions that are performed in under 1.0 s, reflecting an athlete’s strength and power [12,13]. Creating a more predictive TGS for strength/power athletes might be possible by using genetic polymorphisms associated with athletic performance and/or athletic status in weightlifters.
Therefore, the purposes of this study are to (1) investigate the relationship between power-oriented genetic polymorphisms and weightlifting status; (2) create a TGS score using polymorphism; (3) examine the association between the TGS and performance in study 1; and (4) validate the applicability of association of the TGS with weightlifters onto power-oriented athletes in study 2.

2. Materials and Methods

2.1. Participants

Overall, 192 Japanese weightlifters (113 men and 79 women) and 416 controls (151 men: height: 169.0 ± 6.3 cm, weight: 68.5 ± 9.6 kg, age: 51.0 ± 19.07 years; 265 women: height: 156.9 ± 8.1 cm, weight: 54.8 ± 8.1 kg, age: 53.0 ± 17.4 years) living in Tokyo and the surrounding areas were recruited in study 1. The weightlifters were divided into two groups: 67 international-level participants, who took part in international competitions such as world championships and Olympic games, and 125 national-level participants, who took part in the Japanese national competitions. In study 2, 177 strength and power athletes and 416 controls participated. The strength and power athlete group comprised 101 wrestlers (87 men, 14 women; 55 at international and 46 at national levels), 40 male powerlifters (16 at international and 39 at national levels), and 36 national-level throwers (17 men, 19 women).

2.2. Genotyping

Total DNA was extracted from saliva samples using an Oragene DNA Kit (DNA Genotek, ON, Canada) according to the manufacturer’s instructions. ACE I/D rs4341, ACTN3 R577X rs1815739, AGTR2 rs11091046, ALDH2 rs671, CHRNB3 rs4950, CKM rs8111989, CNTFR rs41274853, FTO rs9939609, GALNTL6 rs558129, IGF2 rs680, MCT1 T1470A rs1049434, NOS3 rs207044, PPARGC1A rs8192678, and TRHR rs7832552 polymorphisms were genotyped using a TaqMan SNP genotyping assay and a Real-Time PCR system (Applied Biosystems, Foster City, CA, USA). The Assay IDs for each polymorphism are provided in Supplementary Table S3.

2.3. Genotype Score

Genetic polymorphisms that were associated with power- or strength-oriented athletes were identified by searching for published original articles in PubMed and Google scholar (keywords: “Athlete”, “Power”, “Strength”, and “Status”). Polymorphisms with minor alleles have a frequency of more than 5% in the Japanese population according to jMorp (https://jmorp.megabank.tohoku.ac.jp/, accessed on 5 May 12021), because the sample size was limited. A given frequency of minor alleles was used for this study. Overall, 14 polymorphisms were found to be candidate genes associated with muscle strength and power. However, two polymorphisms were excluded in this study because the AGTR2 rs11091046 polymorphism was located on the sex chromosome (Xq22-q23), the allele frequency was different in the sexes, and the NOS3 rs2040744 polymorphism deviated from the Hardy–Weinberg equilibrium in the control and all participants and was different from the common frequency despite multiple analyses being performed. Therefore, we selected 12 polymorphisms. The TGS was classified into two models. First, a power-oriented model (PWM) comprising 12 candidate genes related to muscle strength and power, and the classification was based on Williams and Folland [14] and methods described by Miyamoto-Mikami et al. [8]. Specifically, we scored 0, 1, and 2 as “less optimal”, “intermediate”, and “optimal” genotypes, respectively. Second, a weightlifting-related model (WRM) was developed based on case–control results for each genetic polymorphism in weightlifters and controls. The genotypes that differed significantly for the genotype, dominant, or recessive models in all the weightlifters or the international group were in the WRM (Table 1). In the order of relevance of homotypes, we scored 0, 1, and 2 as “less optimal”, “intermediate”, and “optimal” genotypes with WRM. A score table of the genetic polymorphisms for each model is shown in Table 1. The genotype score was then totaled and converted to a scale of 0–100 for ease of interpretation. The formula for calculating TGS is as follows:
TGS = 100 24 ×   ( ACE + ACTN 3 + ALDH 2 + CHRNB 3 + CKM + CNTFR + FTO + GALNTL 6 + IGF 2 + MCT 1 + PPARGC 1 A + TRHR )

2.4. Statistical Analyses

All statistical analyses were performed using the statistical software SPSS Statistics version 25 (IBM Japan, Tokyo, Japan) and SNPstats software (https://www.snpstats.net/, accessed on 1 July 2021). χ2 analysis was used to assess the Hardy–Weinberg equilibrium. Associations between the athlete status and each polymorphism were assessed using χ2 analysis under three genetic models (that is, a 3-genotype comparison: dominant, recessive, and additive). In addition, the comparisons of weightlifting and powerlifting performance between the genotypes were analyzed using a one-way analysis of variance (ANOVA). We compared the TGSs between weightlifters and controls using an unpaired t-test. Additionally, the comparison of the TGS between the three groups (that is, the control, and national and international levels) was carried out using ANOVA. Linear regression analysis was performed to estimate the degree of variance in the performance of weightlifters associated with the TGS. p-values < 0.05 were considered statistically significant.

3. Results

The genotype frequencies of all polymorphisms, excluding the ACE I/D, CKM rs8111989, and CNTFR rs41274853 polymorphisms in weightlifters, and the CHRNB3 rs4950 and TRHR rs7832552 polymorphisms in the controls, were consistent with the Hardy–Weinberg equilibrium. The athletes were not often at equilibrium; hence, three polymorphisms were adopted in this study. Meanwhile, the frequencies of CHRNB3 rs4950 and TRHR rs7832552 polymorphisms were equal according to jMorp; therefore, they were adopted in this study. The frequencies of each of the 12 polymorphisms in weightlifters are presented in Table 2 (see Supplementary Table S1 for details). Only six polymorphisms (ACE I/D rs4341, ACTN3 R577X rs1815739, CHRNB3 rs4950, CNTFR rs41274853, MCT1 T1470A rs1049434, and PPARGC1A rs8192678) were found to be associated with weightlifting athlete status.
The TGS based on the 12 polymorphisms in each model is shown in Figure 1A,B. All the PWM groups showed similar scores (controls: 43.6 ± 8.92, national: 42.78 ± 8.53, and international: 45.73 ± 9.55). Of the six genotypes associated with weightlifting status using the case–control study, the TGSs weightlifters were higher than those of the controls (controls: 32.93 ± 13.34, national: 35.53 ± 14.40, and international: 38.60 ± 15.16) and demonstrated a linear trend, as shown in Figure 2A,B. Weightlifters’ performance results based on the Wilks point (total records) were statistically significant for ACTN3 R577X (RR + RX: 193.32 ± 27.25 vs. XX: 184.55 ± 27.61, p = 0.04) and CNTFR rs41274853 (CC: 185.32 ± 23.90 vs. TT + CT: 197 ± 30.30, p = 0.004). A trend (p < 0.1) was observed in the ACE I/D and PPARGC1A polymorphisms (Supplementary Tables S2 and S5). However, regression analysis showed that the WRM was not a significant factor in performance (p = 0.167).
There was no significant difference in the case–control study between the six genotypes in power-oriented athletes (Supplementary Table S4). Furthermore, the TGS of the WRM was not significantly different between power-oriented athletes and the controls (controls: 32.3 ± 13.4, power-oriented athletes: 32.9 ± 13.3), as shown in Figure 3.

4. Discussion

In this study, we investigated the relationship between power-oriented genetic polymorphisms, weightlifting status, and performance; created the TGS score using polymorphism; and examined the associated between TGS and performance in study 1. Additionally, we validated the association of TGS with strength and power in athletes in study 2. The 12 polymorphisms were reported to have strength and power phenotypes in previous studies. Six of the twelve genetic polymorphisms were found to be associated with weightlifter status. There was no significant difference in the score of the 12 genetic polymorphisms between the weightlifters and controls. The WRM score of the six genetic polymorphisms associated with weightlifter status was found to be significantly higher in weightlifters than in the controls. However, the WRM exhibited no significant difference between score and performance.
Six of the twelve genetic polymorphisms were associated with weightlifter status; additionally, its polymorphisms, excluding CHRNB3 rs4950, were reportedly associated with the muscle strength or power phenotype [15,16,17]. In particular, ACE I/D, ACTN3 R577X, CNTFR rs41274853, and PPARGC1A rs8192678 in the WRM associated with elite weightlifters were associated with weightlifter performance. Furthermore, these genetic polymorphisms have also been reported to be associated with muscle strength and power in previous studies. ACE I/D polymorphisms are associated with ACE activation in the blood [18,19]. The II genotype was reported to have low ACE activity in muscle or blood with a higher percentage of type I muscle fibers [20]. On the other hand, several studies reported that the association of ACE I/D polymorphisms with muscle strength, power, and sprint athlete status was shown with the D allele. Wang et al. [21] examined gene frequencies in Caucasian and East Asian competitive swimmers. These results showed a higher frequency of the D allele in Caucasian athletes in short-distance events < 400 m and a higher frequency of the I allele in East Asian athletes, suggesting that the effects of genetic polymorphisms may differ between races. However, the direction of the associated allele from these studies is unknown, but appears to be related to athlete status. In this study, the direction of the relevant allele of the ACE gene differed between case–control and performance, although the reason is not clear. These findings suggest that caution should be exercised when using ACE to examine athletes’ status and performance.
ACTN3 was expressed in type II myofibers only [22], which is important for anchoring actin, and plays a regulatory role in coordinating muscle fiber contraction [23]. However, the XX genotype of ACTN3 R577X did not express ACTN3 protein, and may have been affected by the phenotype. Many studies examining the association between the ACTN3 R577X polymorphism and athletes have been performed. Tharabenjasin et al. [24] conducted a meta-analysis of 38 meta-analyses of elite power-oriented athletes published in 2018, and reported that RR and RX genotypes are associated with elite power athlete status. The CNTFR rs41274853 polymorphism is related to the sprint or power performance and muscle phenotypes [25,26,27]. The reason could be that this polymorphism is located in the 3′-UTR of CNTFR, and it may affect the binding of micro-RNA [27]. Miyamoto-Mikami et al. [27] reported that leg extension power and vertical jump height were higher in the TT genotype of CNTFR rs41274853 polymorphism than in the CC + CT genotype in young or middle-aged males. Muscle strength is directly related to weightlifting performance [13]; therefore, these polymorphisms may be associated with weightlifting status or performance. A previous study reported that mRNA of PPARGC1A expression was lower in those with the A-allele of the PPARGC1A polymorphism than in those with the GG genotype [28]. Additionally, PGC-1 knock-out mice showed a myofiber transition from type I and IIa fibers to type IIx and IIb [29]. Gineviciene et al. [30] examined the gene frequency of the PPARGC1A rs8192678 polymorphism in 114 Russian and 47 Lithuanian strength- and power-oriented athletes and found that the frequency of the AA genotype in strength- and power-oriented athletes was higher than that in the controls.
In this study, a TGS was created using these genetic polymorphisms. However, no significant differences were found between the controls and weightlifters in the WPM, and this may be because 12 polymorphisms were used. Each increase in polymorphisms causes a decrease in the probability of a perfect TGS and may include polymorphisms that do not reflect weightlifting performance. Earlier studies that related the TGS with power-oriented athletes’ status created a TGS with three to seven genetic polymorphisms [5,6,31]. Hence, the WRM was created from six genetic polymorphisms, which may have shown significant differences.
Guilherme and Lancha [7] compared TGSs created via several combinations of 10 genetic polymorphisms in 368 athletes and 818 controls. According to the study, scores above 60 were more common in elite athletes than in non-athlete controls [7]. Consequently, athletes with higher scores may have had more genetic traits than the controls. In this study, the frequency distribution of the participants according to the WRM showed that weightlifters are more overexposed than the controls, with scores ≥ 50.0 (WRM: controls: 15.62%; international: 28.36%; p = 0.02). Based on our results and those of previous studies, it may be necessary to have more than a given score (e.g., 50<) to be successful as an elite athlete.
In this study, the TGS model created for weightlifters could not be reproduced in other power-oriented athletes (wrestlers, powerlifters, and throwers). One of the reasons is the differences in the characteristics and energy supply systems, which could not reflect the same genetic characteristics. Wrestling is a competition of two rounds of 3 min with a 30 sec rest between rounds; this makes it a high-intensity, intermittent exercise requiring physical fitness, such as maximal muscle strength and endurance, as well as anaerobic and aerobic capacity [32]. In powerlifting, all the weightlifting is completed in three events—squat, deadlift, and bench press—and performance improvement may be associated with maximal muscle strength, not fast speed. These are athletes with the same strength and power but with different abilities required for weightlifting competitions, and they may have different genetic characteristics; hence, the TGS model created for weightlifters may not have been applicable to other power-oriented athletes. A previous study also reported different genetic characteristics in a similar event and indicated that different events should not be combined in sports genetic studies, or should at least be examined carefully [33].
A limitation of this study is that it was necessary to consider multiple comparisons and conduct Bonferroni adjustments. The only genetic polymorphism that remained significant after correction for multiple comparisons was the CNTFR rs41274853 polymorphism (p = 0.007). In addition, there may also be different directions of association of polymorphisms in case–control and performance, as in the ACE I/D polymorphism. However, it is necessary to examine the reproducibility of this study in other weightlifter cohorts to confirm its reliability. The polymorphisms examined in the present study represent only a small percentage of the polymorphisms possessed by the human genome. Therefore, it is necessary to perform a comprehensive analysis of polymorphisms using a genome-wide association study which can analyze the entire human genome, and enrichment analysis which is able to analyze their function. In addition, the composite effect of hundreds to thousands of genetic polymorphisms using the polygenic risk score should be examined to create a TGS that is more related to muscle strength and power.

5. Conclusions

Six genetic polymorphisms related to weightlifter status could be identified. The TGS model generated from those genetic polymorphisms was higher in elite weightlifters compared to the controls. However, the TGS model using six polymorphisms could not be applied to weightlifting performance and status in other power athletes.

Supplementary Materials

The following supporting information can be downloaded at: https://www.mdpi.com/article/10.3390/genes13112091/s1, Table S1: Frequency of each genetic polymorphism in weightlifters and controls; Table S2: Characteristics and weightlifting performance among each genetic polymorphism; Table S3: Genetic markers for strength/power athletic status; Table S4: Frequency of each genetic polymorphism in power-oriented athletes and controls; Table S5: Weightlifting performance among six genetic polymorphism.

Author Contributions

Study design: H.H. and N.K. (Naoki Kikuchi); data acquisition: N.K. (Kobatake Naoyuki), R.M., S.M., H.H., A.S., A.K. and M.S.; analysis and interpretation of data: H.H., A.S., A.K. and M.S.; drafting of the work: H.H. and N.K. (Naoki Kikuchi); critical revision of the work: T.N., T.O. and K.N.; final approval of the version to be published: R.M., S.M., M.S., A.S., A.K., N.K. (Kobatake Naoyuki), T.N. and N.K. (Naoki Kikuchi); authors accountable for all aspects of the work ensuring that questions related to the accuracy or integrity of every part of the work were appropriately investigated and resolved: M.S., A.S., A.K., N.K., (Kobatake Naoyuki), R.M., S.M., T.N. and N.K. (Naoki Kikuchi). All authors have read and agreed to the published version of the manuscript.

Funding

This research was funded by JSPS KAKENHI (grant numbers 22K17700 and 22K11506).

Institutional Review Board Statement

The study was conducted according to the guidelines of the Declaration of Helsinki and approved by the Ethics Committee of the Federal Research and Clinical Center of Physical-Chemical Medicine and by the ethics committee of the Nippon Sport Science University (020-G03).

Informed Consent Statement

Informed consent was obtained from all subjects involved in the study.

Data Availability Statement

The data presented in this study are available on request from the corresponding author.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Ahmetov, I.I.; Hall, E.C.R.; Semenova, E.A.; Pranckeviciene, E.; Gineviciene, V. Advances in sports genomics. Adv. Clin. Chem. 2022, 107, 215–263. [Google Scholar] [CrossRef] [PubMed]
  2. Kikuchi, N.; Nakazato, K.; Min, S.K.; Ueda, D.; Igawa, S. The actn3 r577x polymorphism is associated with muscle power in male japanese athletes. J. Strength Cond. Res. 2014, 28, 1783–1789. [Google Scholar] [CrossRef] [PubMed]
  3. Walsh, S.; Liu, D.; Metter, E.J.; Ferrucci, L.; Roth, S.M. ACTN3 genotype is associated with muscle phenotypes in women across the adult age span. J. Appl. Physiol. 2008, 105, 1486–1491. [Google Scholar] [CrossRef]
  4. Ben-Zaken, S.; Meckel, Y.; Lidor, R.; Nemet, D.; Eliakim, A. Genetic profiles and prediction of the success of young athletes’ transition from middle- to long-distance runs: An exploratory study. Pediatr. Exerc. Sci. 2013, 25, 435–447. [Google Scholar] [CrossRef] [PubMed]
  5. Ben-Zaken, S.; Meckel, Y.; Nemet, D.; Eliakim, A. Genetic score of power-speed and endurance track and field athletes. Scand. J. Med. Sci. Sports 2015, 25, 166–174. [Google Scholar] [CrossRef] [PubMed]
  6. Drozdovska, S.B.; Dosenko, V.E.; Ahmetov, I.I.; Ilyin, V.N. The association of gene polymorphisms with athlete status in ukrainians. Biol. Sport 2013, 30, 163–167. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  7. Guilherme, J.; Lancha, A.H., Jr. Total genotype score and athletic status: An exploratory cross-sectional study of a brazilian athlete cohort. Ann. Hum. Genet. 2020, 84, 141–150. [Google Scholar] [CrossRef]
  8. Miyamoto-Mikami, E.; Murakami, H.; Tsuchie, H.; Takahashi, H.; Ohiwa, N.; Miyachi, M.; Kawahara, T.; Fuku, N. Lack of association between genotype score and sprint/power performance in the Japanese population. J. Sci. Med. Sport 2017, 20, 98–103. [Google Scholar] [CrossRef]
  9. Yvert, T.; Miyamoto-Mikami, E.; Murakami, H.; Miyachi, M.; Kawahara, T.; Fuku, N. Lack of replication of associations between multiple genetic polymorphisms and endurance athlete status in Japanese population. Physiol. Rep. 2016, 4, e13003. [Google Scholar] [CrossRef]
  10. Zillikens, M.C.; Demissie, S.; Hsu, Y.-H.; Yerges-Armstrong, L.M.; Chou, W.-C.; Stolk, L.; Livshits, G.; Broer, L.; Johnson, T.; Koller, D.L.; et al. Large meta-analysis of genome-wide association studies identifies five loci for lean body mass. Nat. Commun. 2017, 8, 80. [Google Scholar] [CrossRef]
  11. Liu, X.-G.; Tan, L.-J.; Lei, S.-F.; Liu, Y.-J.; Shen, H.; Wang, L.; Yan, H.; Guo, Y.-F.; Xiong, D.-H.; Chen, X.-D.; et al. Genome-wide association and replication studies identified trhr as an important gene for lean body mass. Am. J. Hum. Genet. 2009, 84, 418–423. [Google Scholar] [CrossRef] [Green Version]
  12. Stone, M.H.; Kirksey, B.K. Physiology of Weightlifting; Lippincott Williams & Wilkins: Philadelphia, PA, USA, 2000; pp. 955–964. [Google Scholar]
  13. Stone, M.H.; Sands, W.A.; Pierce, K.C.; Carlock, J.; Cardinale, M.; Newton, R.U. Relationship of maximum strength to weightlifting performance. Med. Sci. Sports Exerc. 2005, 37, 1037–1043. [Google Scholar] [PubMed]
  14. Williams, A.G.; Folland, J.P. Similarity of polygenic profiles limits the potential for elite human physical performance. J. Physiol. 2008, 586, 113–121. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  15. Kikuchi, N.; Fuku, N.; Matsumoto, R.; Matsumoto, S.; Murakami, H.; Miyachi, M.; Nakazato, K. The association between mct1 t1470a polymorphism and power-oriented athletic performance. Int. J. Sports Med. 2017, 38, 76–80. [Google Scholar] [CrossRef] [PubMed]
  16. Kittilsen, H.T.; Goleva-Fjellet, S.; Freberg, B.I.; Nicolaisen, I.; Stoa, E.M.; Bratland-Sanda, S.; Helgerud, J.; Wang, E.; Saebo, M.; Storen, O. Responses to maximal strength training in different age and gender groups. Front. Physiol. 2021, 12, 636972. [Google Scholar] [CrossRef] [PubMed]
  17. Moran, C.N.; Vassilopoulos, C.; Tsiokanos, A.; Jamurtas, A.Z.; Bailey, M.E.S.; Montgomery, H.E.; Wilson, R.H.; Pitsiladis, Y.P. The associations of ace polymorphisms with physical, physiological and skill parameters in adolescents. Eur. J. Hum. Genet. 2006, 14, 332–339. [Google Scholar] [CrossRef]
  18. Higashimori, K.; Zhao, Y.; Higaki, J.; Kamitani, A.; Katsuya, T.; Nakura, J.; Miki, T.; Mikami, H.; Ogihara, T. Association analysis of a polymorphism of the angiotensin converting enzyme gene with essential hypertension in the Japanese population. Biochem. Biophys. Res. Commun. 1993, 191, 399–404. [Google Scholar] [CrossRef]
  19. Rigat, B.; Hubert, C.; Alhenc-Gelas, F.; Cambien, F.; Corvol, P.; Soubrier, F. An insertion/deletion polymorphism in the angiotensin i-converting enzyme gene accounting for half the variance of serum enzyme levels. J. Clin. Investig. 1990, 86, 1343–1346. [Google Scholar] [CrossRef] [Green Version]
  20. Zhang, B.; Tanaka, H.; Shono, N.; Miura, S.; Kiyonaga, A.; Shindo, M.; Saku, K. The i allele of the angiotensin-converting enzyme gene is associated with an increased percentage of slow-twitch type i fibers in human skeletal muscle. Clin. Genet. 2003, 63, 139–144. [Google Scholar] [CrossRef]
  21. Wang, G.; Mikami, E.; Chiu, L.-L.; De Perini, A.; Deason, M.; Fuku, N.; Miyachi, M.; Kaneoka, K.; Murakami, H.; Tanaka, M.; et al. Association analysis of ace and actn3 in elite caucasian and east asian swimmers. Med. Sci. Sports Exerc. 2013, 45, 892–900. [Google Scholar] [CrossRef]
  22. North, K. Why is α-actinin-3 deficiency so common in the general population? The evolution of athletic performance. Twin Res. Hum. Genet. 2008, 11, 384–394. [Google Scholar] [CrossRef] [PubMed]
  23. Blanchard, A.; Ohanian, V.; Critchley, D. The structure and function of α-actinin. J. Muscle Res. Cell Motil. 1989, 10, 280–289. [Google Scholar] [CrossRef] [PubMed]
  24. Tharabenjasin, P.; Pabalan, N.; Jarjanazi, H. Association of the actn3 r577x (rs1815739) polymorphism with elite power sports: A meta-analysis. PLoS ONE 2019, 14, e0217390. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  25. Roth, S.M.; Metter, E.J.; Lee, M.R.; Hurley, B.F.; Ferrell, R.E. C174t polymorphism in the cntf receptor gene is associated with fat-free mass in men and women. J. Appl. Physiol. 2003, 95, 1425–1430. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  26. Homma, H.; Kobatake, N.; Sekimoto, Y.; Saito, M.; Mochizuki, Y.; Okamoto, T.; Nakazato, K.; Nishiyama, T.; Kikuchi, N. Ciliary neurotrophic factor receptor rs41274853 polymorphism is associated with weightlifting performance in japanese weightlifters. J. Strength Cond. Res. 2020, 34, 3037–3041. [Google Scholar] [CrossRef] [PubMed]
  27. Miyamoto-Mikami, E.; Fujita, Y.; Murakami, H.; Ito, M.; Miyachi, M.; Kawahara, T.; Fuku, N. Cntfr genotype and sprint/power performance: Case-control association and functional studies. Int. J. Sports Med. 2016, 37, 411–417. [Google Scholar] [CrossRef]
  28. Ling, C.; Poulsen, P.; Carlsson, E.; Ridderstråle, M.; Almgren, P.; Wojtaszewski, J.; Beck-Nielsen, H.; Groop, L.; Vaag, A. Multiple environmental and genetic factors influence skeletal muscle pgc-1α and pgc-1β gene expression in twins. J. Clin. Investig. 2004, 114, 1518–1526. [Google Scholar] [CrossRef] [Green Version]
  29. Handschin, C.; Chin, S.; Li, P.; Liu, F.; Maratos-Flier, E.; Lebrasseur, N.K.; Yan, Z.; Spiegelman, B.M. Skeletal muscle fiber-type switching, exercise intolerance, and myopathy in pgc-1α muscle-specific knock-out animals. J. Biol. Chem. 2007, 282, 30014–30021. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  30. Gineviciene, V.; Jakaitiene, A.; Aksenov, M.O.; Aksenova, A.V.; Druzhevskaya, A.M.; Astratenkova, I.V.; Egorova, E.S.; Gabdrakhmanova, L.J.; Tubelis, L.; Kucinskas, V.; et al. Association analysis of ace, actn3 and ppargc1a gene polymorphisms in two cohorts of European strength and power athletes. Biol. Sport 2016, 33, 199–206. [Google Scholar] [CrossRef]
  31. Ruiz, J.R.; Arteta, D.; Buxens, A.; Artieda, M.; Gomez-Gallego, F.; Santiago, C.; Yvert, T.; Moran, M.; Lucia, A. Can we identify a power-oriented polygenic profile? J. Appl. Physiol. 2010, 108, 561–566. [Google Scholar] [CrossRef]
  32. Chaabene, H.; Negra, Y.; Bouguezzi, R.; Mkaouer, B.; Franchini, E.; Julio, U.; Hachana, Y. Physical and physiological attributes of wrestlers: An update. J. Strength Cond. Res. 2017, 31, 1411–1442. [Google Scholar] [CrossRef] [PubMed]
  33. Ben-Zaken, S.; Eliakim, A.; Nemet, D.; Meckel, Y. Genetic variability among power athletes: The stronger vs. The faster. J. Strength Cond. Res. 2019, 33, 1505–1511. [Google Scholar] [CrossRef] [PubMed]
Genes 13 02091 g001 550
Figure 1. PWM of the controls and weightlifters (A) and of the controls and the national and international groups (B). The values are presented as mean ± SD.
Figure 1. PWM of the controls and weightlifters (A) and of the controls and the national and international groups (B). The values are presented as mean ± SD.
Genes 13 02091 g001
Genes 13 02091 g002 550
Figure 2. WRM of controls and weightlifters (A) and of the controls and the national and international groups (B). The values are presented as mean ± SD.
Figure 2. WRM of controls and weightlifters (A) and of the controls and the national and international groups (B). The values are presented as mean ± SD.
Genes 13 02091 g002
Genes 13 02091 g003 550
Figure 3. WRM of power-oriented athletes and the controls. The values are presented as mean ± SD.
Figure 3. WRM of power-oriented athletes and the controls. The values are presented as mean ± SD.
Genes 13 02091 g003
Table
Table 1. Polymorphisms of each model in weightlifters.
Table 1. Polymorphisms of each model in weightlifters.
Gene Symbolrs NumberPolymorphismGenotype Score Model
PWMWRM
ACErs4341I/DDD = 0ID = 1II = 2DD = 2ID = 1II = 0
ACTN3rs1815739C > TCC = 2TC = 1TT = 0CC = 2TC = 1TT = 0
ALDH2rs671G > AGG = 2GA = 1AA = 0
CHRNB3rs4950A > GAA = 2GA = 1GG = 0AA = 0GA = 1GG = 2
CKMrs8111989A > GAA = 0GA = 1GG = 2
CNTFRrs41274853C > TCC = 0CT = 1TT = 2CC = 0CT = 1TT = 2
FTOrs9939609T > ATT = 0TA = 1AA = 2
GALNT6rs558129C > TCC = 0CT = 1TT = 2
IGF2rs680G > AGG = 2GA = 1AA = 0
MCT1rs1049434A > TAA = 0TA = 1TT =2AA = 0TA = 1TT = 2
PPARGC1Ars8192678A > GAA = 2GA = 1GG = 0AA = 2TA = 1GG = 0
TRHRrs7832552T > CTT = 2CT = 1CC = 0
PWM: power-oriented whole model; WRM: weightlifting-related model.
Table
Table 2. Frequency of 12 polymorphisms in weightlifters and controls.
Table 2. Frequency of 12 polymorphisms in weightlifters and controls.
GeneGenotypen(%)p-Value
All WeightliftersInternationalControlsAll Weightlifters vs. ControlsInternational vs. Controls
(n = 192)(n = 67)(n = 416)DominantRecessiveAlleleDominantRecessiveAllele
ACEDD40(21)12(18)49(12)DD/II + IDDD + ID/IID/IDD/II + IDDD + ID/IID/I
rs4341ID79(41)22(33)200(48)0.0030.0620.0600.1610.1600.738
II73(38)33(49)167(40)
ACTN3RR49(25)21(32)84(20)RR + RX/XXRR/RX + XXR/XRR + RX/XXRR/RX + XXR/X
rs1815739RX86(45)31(46)226(55)0.2760.1390.8500.5800.0400.120
XX57(30)15(22)106(25)
ALDH2GG99(51)34(51)232(56)GG + GA/AAGG/GA + AAG/AGG + GA/AAGG/GA + AAG/A
rs671GA76(40)26(39)149(36)0.3320.3960.3900.4430.3900.390
AA17(9)7(10)35(8)
CHRNB3AA127(66)47(70)323(77)AA/GA + GG)AA + GA/GGA/GAA/GA + GG)AA + GA/GGA/G
rs4950GA61(32)19(29)77(19)0.0020.2570.0200.1700.3310.418
GG4(2)1(1)16(4)
CKMAA152(79)52(78)308(74)AA/GA + GG)AA + GA/GGA/GAA/GA + GG)AA + GA/GGA/G
rs8111989GA34(18)13(19)98(24)0.6000.1700.2900.7760.5330.640
GG6(3)2(3)10(2)
CNTFRCC104(54)26(39)210(50)CC/CT + TTCC + CT/TTC/TCC/CT + TTCC + CT/TTC/T
rs41274853CT64(33)28(42)170(41)0.3970.1390.9700.0760.0070.008
TT24(13)13(19)36(9)
FTOTT118(61)44(66)269(65)TT/TA + AATT + TA/AAT/ATT/TA + AATT + TA/AAT/A
rs9989609TA65(34)21(31)130(31)0.4450.7330.4400.7700.6230.936
AA9(5)2(3)17(4)
GALNTL6CC137(71)48(72)304(73)CC/CT + TTCC + CT/TTC/TCC/CT + TTCC + CT/TTC/T
rs558129CT49(26)17(25)101(24)0.6580.7380.6100.8060.8720.780
TT6(3)2(3)11(3)
IGF2 rCC80(42)25(37)143(34)CC/CT + TTCC + CT/TTC/TCC/CT + TTCC + CT/TTC/T
s680CT83(43)32(48)193(46)0.2170.2170.0500.4000.4000.430
TT29(15)10(15)80(20)
MCT1AA75(39)28(42)199(48)AA/TA + TTAA/TA vs. TTA/TAA/TA + TTAA/TA vs. TTA/T
rs1049434TA91(47)30(45)175(42)0.0430.2100.0350.3570.4090.270
TT26(14)9(13)42(10)
PPARGC1AAA35(18)13(19)79(19)AA/GA + GG)AA + GA/GGA/GAA/GA + GG)AA + GA/GGA/G
rs8192678GA102(53)38(57)184(44)0.8230.0490.2200.9360.0390.147
GG55(29)16(24)153(37)
TRHRTT52(27)13(19)129(31)TT/CT + CCTT + CT/CCT/CTT/CT + CCTT + CT/CCT/C
rs7832552CT98(51)32(48)175(42)0.3250.1830.8500.0530.3100.059
CC42(22)22(33)112(27)
Full names of the genes are: ACE: angiotensin I-converting enzyme; ACTN3: α-actinin-3; ALDH2: mitochondrial aldehyde dehydrogenase 2; CHRNB3: cholinergic receptor, nicotinic, β 3; CKM: Muscle-Specific Creatine Kinase; CNTFR: cilliary neurotrophic factor receptor; FTO: fat mass and obesity-associated gene; GALNTL6: N-acetylgalactosaminyltransferase-like 6 gene; IGF2: insulin-like growth factor2; MCT1: monocarboxylate transporter 1 gene; PPARGC1A: peroxisome proliferator-activated receptor γ coactivator 1 α; and TRHR: thyrotropin-releasing hormone receptor. The ACE I/D polymorphism (rs4340) was determined using the rs4341 polymorphism, which is in perfect LD with the ACE I/D polymorphism (rs4340). PWM: power-oriented whole model; WRM: weightlifting-related model.
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Homma, H.; Saito, M.; Saito, A.; Kozuma, A.; Matsumoto, R.; Matsumoto, S.; Kobatake, N.; Okamoto, T.; Nakazato, K.; Nishiyama, T.; et al. The Association between Total Genotype Score and Athletic Performance in Weightlifters. Genes 2022, 13, 2091. https://doi.org/10.3390/genes13112091

AMA Style

Homma H, Saito M, Saito A, Kozuma A, Matsumoto R, Matsumoto S, Kobatake N, Okamoto T, Nakazato K, Nishiyama T, et al. The Association between Total Genotype Score and Athletic Performance in Weightlifters. Genes. 2022; 13(11):2091. https://doi.org/10.3390/genes13112091

Chicago/Turabian Style

Homma, Hiroki, Mika Saito, Aoto Saito, Ayumu Kozuma, Ryutaro Matsumoto, Shingo Matsumoto, Naoyuki Kobatake, Takanobu Okamoto, Koichi Nakazato, Tetsunari Nishiyama, and et al. 2022. "The Association between Total Genotype Score and Athletic Performance in Weightlifters" Genes 13, no. 11: 2091. https://doi.org/10.3390/genes13112091

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop